ADMA BIOLOGICS, INC.
End-to-end biopharma making plasma-derived biologics for immune-compromised patients.
ADMA | NDAQ
Overview
Corporate Details
- ISIN(s):
- US0008991046
- LEI:
- Country:
- United States of America
- Address:
- C/O ADMA BIOLOGICS, INC., 7446 RAMSEY
- Website:
- https://www.admabiologics.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
ADMA Biologics, Inc. is an end-to-end commercial biopharmaceutical company that develops, manufactures, and markets specialty plasma-derived biologics. Its portfolio of FDA-approved immune globulin (Ig) products is designed to treat immune-compromised patients and individuals at risk for certain infectious diseases. The company operates a vertically integrated business model, managing the process from plasma collection to final product manufacturing. ADMA utilizes a patented immunotechnology and a proprietary microneutralization assay to quantitatively measure neutralizing antibody levels in donor plasma. In addition to its own product lines, the company also provides contract manufacturing services.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ADMA BIOLOGICS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ADMA BIOLOGICS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ADMA BIOLOGICS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
